132 related articles for article (PubMed ID: 20198479)
41. Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
Goldwaser EL; Acharya NK; Wu H; Godsey GA; Sarkar A; DeMarshall CA; Kosciuk MC; Nagele RG
J Alzheimers Dis; 2020; 74(1):345-361. PubMed ID: 32039847
[TBL] [Abstract][Full Text] [Related]
42. Increased heat shock transcription factor 1 in the cerebellum reverses the deficiency of Purkinje cells in Alzheimer's disease.
Jiang YQ; Wang XL; Cao XH; Ye ZY; Li L; Cai WQ
Brain Res; 2013 Jun; 1519():105-11. PubMed ID: 23665061
[TBL] [Abstract][Full Text] [Related]
43. Stereological quantification of the cerebellum in patients with Alzheimer's disease.
Andersen K; Andersen BB; Pakkenberg B
Neurobiol Aging; 2012 Jan; 33(1):197.e11-20. PubMed ID: 20728248
[TBL] [Abstract][Full Text] [Related]
44. Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid.
Ohyagi Y; Tsuruta Y; Motomura K; Miyoshi K; Kikuchi H; Iwaki T; Taniwaki T; Kira J
J Neurosci Methods; 2007 Jan; 159(1):134-8. PubMed ID: 16860394
[TBL] [Abstract][Full Text] [Related]
45. DNA Damage Increases Secreted Aβ40 and Aβ42 in Neuronal Progenitor Cells: Relevance to Alzheimer's Disease.
Welty S; Thathiah A; Levine AS
J Alzheimers Dis; 2022; 88(1):177-190. PubMed ID: 35570488
[TBL] [Abstract][Full Text] [Related]
46. Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease.
Hashimoto M; Bogdanovic N; Nakagawa H; Volkmann I; Aoki M; Winblad B; Sakai J; Tjernberg LO
J Cell Mol Med; 2012 Aug; 16(8):1686-700. PubMed ID: 21883897
[TBL] [Abstract][Full Text] [Related]
47. Regulation of intracellular calcium in cortical neurons transgenic for human Abeta40 and Abeta42 following nutritive challenge.
Shirwany NA; Xie J; Guo Q
Int J Clin Exp Med; 2009 Jun; 2(2):149-58. PubMed ID: 19684887
[TBL] [Abstract][Full Text] [Related]
48. A neuronal aging pattern unique to humans and common chimpanzees.
Gilissen EP; Leroy K; Yilmaz Z; Kövari E; Bouras C; Boom A; Poncelet L; Erwin JM; Sherwood CC; Hof PR; Brion JP
Brain Struct Funct; 2016 Jan; 221(1):647-64. PubMed ID: 25381006
[TBL] [Abstract][Full Text] [Related]
49. Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.
Nunomura A; Tamaoki T; Tanaka K; Motohashi N; Nakamura M; Hayashi T; Yamaguchi H; Shimohama S; Lee HG; Zhu X; Smith MA; Perry G
Neurobiol Dis; 2010 Mar; 37(3):731-7. PubMed ID: 20034567
[TBL] [Abstract][Full Text] [Related]
50. Pathology associated with AAV mediated expression of beta amyloid or C100 in adult mouse hippocampus and cerebellum.
Drummond ES; Muhling J; Martins RN; Wijaya LK; Ehlert EM; Harvey AR
PLoS One; 2013; 8(3):e59166. PubMed ID: 23516609
[TBL] [Abstract][Full Text] [Related]
51. Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains.
D'Andrea MR; Nagele RG; Gumula NA; Reiser PA; Polkovitch DA; Hertzog BM; Andrade-Gordon P
Neurosci Lett; 2002 Apr; 323(1):45-9. PubMed ID: 11911987
[TBL] [Abstract][Full Text] [Related]
52. Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease.
Mochizuki A; Tamaoka A; Shimohata A; Komatsuzaki Y; Shoji S
Lancet; 2000 Jan; 355(9197):42-3. PubMed ID: 10615894
[TBL] [Abstract][Full Text] [Related]
53. Purkinje cell loss and astrocytosis in the cerebellum in familial and sporadic Alzheimer's disease.
Fukutani Y; Cairns NJ; Rossor MN; Lantos PL
Neurosci Lett; 1996 Aug; 214(1):33-6. PubMed ID: 8873125
[TBL] [Abstract][Full Text] [Related]
54. Increased melatonin 1a-receptor immunoreactivity in the hippocampus of Alzheimer's disease patients.
Savaskan E; Olivieri G; Meier F; Brydon L; Jockers R; Ravid R; Wirz-Justice A; Müller-Spahn F
J Pineal Res; 2002 Jan; 32(1):59-62. PubMed ID: 11841602
[TBL] [Abstract][Full Text] [Related]
55. Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation.
Turner RS; Suzuki N; Chyung AS; Younkin SG; Lee VM
J Biol Chem; 1996 Apr; 271(15):8966-70. PubMed ID: 8621541
[TBL] [Abstract][Full Text] [Related]
56. Morphological and quantitative analysis of cerebellar cortical cells in Alzheimer's disease.
Stępień T; Wierzba-Bobrowicz T; Lewandowska E; Szpak G
Folia Neuropathol; 2012; 50(3):250-60. PubMed ID: 23023339
[TBL] [Abstract][Full Text] [Related]
57. Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restriction.
Mallard C; Loeliger M; Copolov D; Rees S
Neuroscience; 2000; 100(2):327-33. PubMed ID: 11008170
[TBL] [Abstract][Full Text] [Related]
58. Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.
Gerschütz A; Heinsen H; Grünblatt E; Wagner AK; Bartl J; Meissner C; Fallgatter AJ; Al-Sarraj S; Troakes C; Ferrer I; Arzberger T; Deckert J; Riederer P; Fischer M; Tatschner T; Monoranu CM
J Alzheimers Dis; 2014; 40(1):135-42. PubMed ID: 24334724
[TBL] [Abstract][Full Text] [Related]
59. The cytosolic inclusion bodies that consist of splice variants that lack exon 5 of the presenilin-2 gene differ obviously from Hirano bodies observed in the brain from sporadic cases of Alzheimer's disease patients.
Manabe T; Katayama T; Sato N; Kudo T; Matsuzaki S; Imaizumi K; Tohyama M
Neurosci Lett; 2002 Aug; 328(2):198-200. PubMed ID: 12133587
[TBL] [Abstract][Full Text] [Related]
60. Glycosaminoglycans from aged human hippocampus have altered capacities to regulate trophic factors activities but not Aβ42 peptide toxicity.
Huynh MB; Villares J; Díaz JE; Christiaans S; Carpentier G; Ouidja MO; Sissoeff L; Raisman-Vozari R; Papy-Garcia D
Neurobiol Aging; 2012 May; 33(5):1005.e11-22. PubMed ID: 22035591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
